Prof. Dr. Jessica Bertrand
July 2, 2026 | 1:00 p.m. to 2:00 p.m.Title:
“PMEDM Surface Modification for the Production of Antibacterial Implant Surfaces”
Summary:
"Periprosthetic joint infections (PJI) are a common reason for orthopedic revision surgeries. It has been shown that the silver surface modification of a titanium alloy (Ti–6Al–4V) by PMEDM (powder mixed electrical discharge machining) exhibits an anti-adhesive effect on Staphylococcus spp. The attachment of S. aureus on the PMEDM modified surfaces is significantly lower than on comparative control samples, independently of the roughness and thickness of the tested surface properties. Bacterial proliferation, however, is not affected by the silver content in the surface layer. We observed a long-term effect of antibacterial capacity in vitro, as well as in vivo. An induction of ROS, as indicator for oxidative stress, was observed in the bacteria, but not in osteoblast-like cells. No influence on the in vitro osteoblast function was observed, whereas osteoclast formation was drastically reduced on the silver surface. No changes in cell death, metabolic activity and oxidative stress was measured in osteoblasts. There is a slight release of silver ions under corrosive conditions, which can be adjusted by machining parameters. Therefore, PMEDM using silver nano-powder admixed to the dielectric represents a promising technology to shape and concurrently modify implant surfaces to reduce infections while at the same time optimizing bone ingrowth of endoprosthesis." (Source: Jessica Bertrand)
Dr. Paul Johan Høl
June 15, 2026 | 2:00 p.m. to 3:00 p.m.Title:
“Blood and tissue analysis in patients with failed Orthopaedic implants due to aseptic loosening and osteolysis”
Summary:
"This presentation outlines integrated blood and tissue analysis methods used to investigate failure mechanisms in orthopaedic implants, with a focus on aseptic loosening and periprosthetic osteolysis. Using retrieval analysis from revision surgeries, the study combines mechanical evaluation of explanted prostheses, histological assessment of periprosthetic tissues, and trace element quantification in blood.
A central finding across multiple case series is that implant wear generates particles of varying composition (polymer, metal, ceramic), which accumulate in surrounding tissue and trigger a chronic inflammatory response characterized by macrophage activation, multinucleated giant cells, and lymphocyte involvement. Particle load, size distribution, and composition reflect implant-specific failure pathways and contribute to osteolysis.
Advanced analytical techniques—including SEM-EDS, TEM, ICP-MS, and histopathology—enable detailed characterization of wear debris and systemic exposure. Blood metal ion levels (e.g. Ti, Co, Cr and Zr) show significant correlation with implant wear and mechanical damage, supporting their role as potential biomarkers.
Retrieval case studies highlight how implant design factors, such as surface roughness and material combinations, influence wear and failure rates. The findings emphasize that no single method is sufficient; instead, a multimodal approach linking mechanical, biological, and systemic data is essential to fully understand implant failure and improve patient safety and future implant design." (Source: Paul Johan Høl)
Dr. Anne Bernhardt
March 5, 2026 | 1:30 p.m. to 3:00 p.m.Title:
"In vitro bone models based on primary human cells – challenges and potential"
Summary:
"In vitro bone models have become essential tools for drug development and regenerative medicine approaches. To mimic the situation in native bone tissue, in vitro bone models should involve not only osteoblasts and osteoclasts, but also osteocytes. However, primary human OCY are hard to isolate from bone tissue and cannot be further expanded in vitro due to their post-mitotic state. Moreover, the simultaneous cultivation and differentiation of cells with discrete requirements concerning media composition is challenging. Another challenge is the separation of the different (human) cell species for analysis. We have been working a couple of years on the formation of osteocyte-containing in vitro bone models comprising solely primary human cells. Starting with co-cultures of osteocytes and other bone cells, we went further to basic and advanced triple cultures of bone cells. After having created a functional in vitro triple culture model, human endothelial cells were implemented to perform quadruple cultures, since vascularization is crucial for bone regeneration. Finally, an in vitro bone model of four cells types with stable expression of all specific markers was established." (Source: Anne Bernhardt)
Prof. Dr. Eva Hedlund
November 27, 2025 | 1:00 p.m. to 2:15 p.m.Title:
"Spatial sequencing and 3D in vitro modelling to decode mechanisms of neuronal vulnerability in amyotrophic lateral sclerosis"
Summary:
"Neurodegenerative diseases are characterised by the selective loss of particular neuron types with subsequent clinical features. My laboratory is interested in elucidating mechanisms of neuronal vulnerability and resilience with the goal of identifying new molecular targets for the treatment of neurodegenerative diseases. Here, we have a particular emphasis on the lethal motor neuron disease amyotrophic lateral sclerosis (ALS). This talk will focus on our use of single cell RNA sequencing to elucidate how different neuron types, derived from human induced pluripotent stem cells, respond to ALS-causative mutations and how this gives clues to the demise of vulnerable motor neurons and their potential rescue. As motor neurons are highly polarised cells we also analyse the RNA content of neural processes (using Axon-seq) to investigate changes in subcellular distribution of mRNAs with disease, defects that are not necessarily revealed when somas are investigated. Here we further test targets in zebrafish to explore impact on axon growth and maintenance of connections with muscle targets. Finally, the talk will discuss how to generate the cell types of the posterior body axis (from the neck and down), from stem cells in a dish, to model human motor neuron disease using multi-organoid systems, of precise positions on the anterior-posterior body axis." (Source: Eva Hedlund)
Prof. Dr.-Ing. Stephan Barcikowski
October 30, 2025 | 1:00 p.m. to 2:00 p.m.Title:
"Shaping Ion Release from Biomaterials: From Design and Matrix Effects to Bio-Responses"
Summary:
"The biological performance of biomaterials is profoundly influenced by the release of ions from metallic implants, coatings, nanoparticles, and bioactive composites. Understanding the interplay between ion release kinetics, material composition, and matrix effects is crucial for designing biomaterials or nanoparticles that combine stability with functionality in the host environment. In this talk, we will address the fundamental mechanisms of ion release from elemental, mixed-elemental, and alloy systems such as Ag, Cu, Zn, Fe, and Ni, as well as bimetallic systems like FeNi and AgAu. The modulation of ion release through biological matrices—including albumin or citrate-rich environments—will be highlighted as a decisive factor shaping cellular responses and local tissue compatibility.
In close alignment with the mission of the Research Training Group 2901 SYLOBIO, special attention will be given to how ion release contributes to bioresponses. Functional consequences of controlled ion release in biomedical applications will be presented using selected case studies: from enhanced endothelialization and implant integration, to the challenges of endothelialisation during lung assist device development or hydrogel 3D-Printing, and further applications spanning bioactive glasses as well as hearing implant coatings. In particular, we will revisit pioneering studies that have shaped the understanding of metal-doped biomaterials—still widely cited today—and connect them to recent progress in polymer doping, additive manufacturing of Ag-doped (bio)polymers, and electrospun Zn-containing caprolactone nanofibers. Advanced analytical methods, including high-resolution multiphoton confocal microscopy, provide new insights into nanoparticle dispersion and structure–function correlations.
Taken together, these advances illustrate how rational tailoring of ion release and composite architecture enables biomaterials to move beyond inert substitutes towards active mediators of biological processes. By bridging insights from alloy chemistry, surface science, and biofunctional testing, the work aims to contribute to a systematic framework for designing next-generation materials with controlled bioactivity." (Source: Stephan Barcikowski, Christoph Rehbock)
Prof. Dr. Frank Schwarz
September 23, 2025 | 1:00 p.m. to 2:00 p.m.Themes of the lecture:
"Pathogenesis and Diagnosis of Peri-Implantitis: Emerging Risk Factors, Biomarkers, and Systemic Interactions”
“Innovative Strategies in Peri-Implantitis Management. Translating Molecular Insights into Targeted Therapies”
Prof. Dr. Eberhard Voit
June 23, 2025 | 1:00 p.m. to 2:30 p.m.Title:
"Overview of the role of modeling for individualized medicine"
Summary:
"Computational systems biology and systems medicine have emerged from obscurity and are in the process of moving center stage in the biomedical sciences. Indeed, they are gradually approaching a level of sophistication that will soon be sufficient to assist with medical diagnoses and propose novel treatments. The new systemic approaches will also eventually permit personalized treatments and make predictions regarding health trajectories at an individualized level. This presentation will discuss the state of the art in the emerging application of biomedical systems thinking to personalized medicine and predictive health and outline the challenges that need to be overcome to achieve success. These challenges are primarily due to the innate complexity of the human body and its many subsystems, which is caused by simultaneous molecular and physiological operation at different levels, the involvement of uncounted components and interactions, the nonlinearity of most processes, and numerous phenomena involving thresholds that are not directly measurable and differ within the human population." (Source: Eberhard Voit)
Prof. Dr. Mihaela Roxana Cimpan
March 27, 2025 | 1:00 p.m. to 2 p.m.Title:
"Towards safer and sustainable-by-design nanomaterials: New Approach methodologies"
Summary:
"The NanoSafe & NanoMedicine group at the Department of Clinical Dentistry, Faculty of Medicine at the University of Bergen has worked on the development of in vitro biological models and of methods that are less prone to potential interferences of nanomaterials (NMs) with assays or detection systems. Key biological processes and mechanisms have been investigated and key biological markers were identified. To avoid NM-induced interferences, label-free electric cell-substrate impedance sensing and cyclic voltammetry were implemented to evaluate the viability and proliferation of cells and oxidative stress, respectively.
Our work contributes to a reliable and more realistic assessment of NMs’ health effects through the development and implementation of new approach methodologies for next generation risk assessment (NGRA). Further, the in silico modelling showed promising results on identification of descriptors for cytotoxicity and grouping of NMs, to support integrated approaches for testing and assessment (IATA) of NMs for NGRA." (Source: Mihaela Roxana Cimpan)
Prof. Dr. Stefan Rose-John
November 28, 2024 | 10:45 a.m. to 11:30 a.m.Title:
"The Complex Biology of Interleukin-6: Therapeutic Concepts"



